|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000350051
|
BIRC5
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000350051
|
BIRC5
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000350051
|
BIRC5
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000350051
|
BIRC5
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000350051
|
BIRC5
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000350051
|
BIRC5
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000350051
|
BIRC5
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000350051
|
BIRC5
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000350051
|
BIRC5
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000350051
|
BIRC5
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000350051
|
BIRC5
|
DB09086
|
Eugenol
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5
|
DB00515
|
Cisplatin
|
ovarian cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5
|
DB17062
|
Sepantronium
|
ovarian cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5
|
DB17048
|
Plumbagin
|
glioma
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5
|
NA
|
survivin blocker YM155
|
vascular restenosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB02546 (EXPT02902)
|
Vorinostat (SAHA)
|
lung cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB02546 (EXPT02902)
|
Vorinostat (SAHA)
|
lung cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB02546 (EXPT02902)
|
Vorinostat (SAHA)
|
lung cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
NA
|
NC043
|
colon cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
NA
|
YM155
|
undifferentiated pleomorphic sarcoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
NA
|
YM155
|
malignant fibrous histiocytoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
NA
|
XZH5
|
pancreatic cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
NA
|
XZH5
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
NA
|
Methyl jasmonate
|
colon cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB12681
|
Salirasib
|
hepatocellular carcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5
|
NA
|
Piperlongumine
|
acute lymphoblastic leukemia
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
NA
|
YM155
|
acute lymphoblastic leukemia
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB00188 (APRD00828, DB07475)
|
Bortezomib
|
glioma
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB00159 (NUTR00024)
|
Icosapent (eicosapentaenoic acid)
|
leukemia
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB00605 (APRD01243)
|
Sulindac
|
oral cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB06810
|
Mithramycin A
|
ewing sarcoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB09216
|
Tolfenamic acid
|
ewing sarcoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB11135
|
Selenium
|
cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB11638
|
Dihydroartemisinin
|
squamous cell carcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB12843
|
Oleandrin
|
osteosarcoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
NA
|
YM155
|
malignant peripheral nerve sheath tumors
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB11875
|
3,3-diindolylmethane
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB04865
|
Homoharringtonine
|
hepatocellular carcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB00503 (APRD00312)
|
Ritonavir
|
lung cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB00605 (APRD01243)
|
Sulindac
|
colorectal cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB09298
|
Silibinin
|
laryngeal squamous cell carcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000350051
|
BIRC5 (SURVIVIN)
|
DB09298
|
Silibinin
|
bladder cancer
|
down-regulated
|
validated
|
more...
|